Library Subscription: Guest
Critical Reviews™ in Biomedical Engineering

Published 6 issues per year

ISSN Print: 0278-940X

ISSN Online: 1943-619X

SJR: 0.262 SNIP: 0.372 CiteScore™:: 2.2 H-Index: 56

Indexed in

Theoretical Models for Drug Delivery to Solid Tumors

Volume 25, Issue 6, 1997, pp. 503-571
DOI: 10.1615/CritRevBiomedEng.v25.i6.20
Get accessGet access

ABSTRACT

The effectiveness of anti-cancer drug therapies is often limited by the difficulty of achieving drug delivery throughout solid tumors. Mathematical models permit an analysis of the factors leading to inadequate drug delivery to tumors and can suggest strategies for improving delivery. An overview is given of key factors that influence drug delivery and the extent to which they have been incorporated into existing theoretical models. These factors include spatial gradients of drug concentration and other variables within tumors and other parts of the body, and the relative magnitudes of the time scales involved in drug transport, tumor cell kinetics, and host toxicity. Models for both systemic and regional delivery methods are considered, including intravenous, intraarterial, intraperitoneal, intrathecal, and intratumoral delivery. Strategies for improving delivery are discussed, including use of two-step therapies, hyperthermia, liposome encapsulation, and magnetic targeting. Until now, modeling has mainly developed in separate subfields of tumor growth and cell kill kinetics, compartmental modeling of the body, spatially distributed models for single tissues, radiation dose calculations, tumor oxygenation, tumor blood flow, and cellular pharmacokinetics. In the future, models that integrate these subfields should be developed.

CITED BY
  1. Cheung Richard Y., Rauth Andrew M., Yu Wu Xiao, In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulations, Anti-Cancer Drugs, 16, 4, 2005. Crossref

  2. Garimella T. S., Ross D. D., Eiseman J. L., Mondick J. T., Joseph E., Nakanishi T., Bates S. E., Bauer K. S., Plasma pharmacokinetics and tissue distribution of the breast cancer resistance protein (BCRP/ABCG2) inhibitor fumitremorgin C in SCID mice bearing T8 tumors, Cancer Chemotherapy and Pharmacology, 55, 2, 2005. Crossref

  3. Chiu B, Coburn J, Pilichowska M, Holcroft C, Seib F P, Charest A, Kaplan D L, Surgery combined with controlled-release doxorubicin silk films as a treatment strategy in an orthotopic neuroblastoma mouse model, British Journal of Cancer, 111, 4, 2014. Crossref

  4. Zhang Aili, Mi Xipeng, Yang Geer, Xu Lisa X., Numerical Study of Thermally Targeted Liposomal Drug Delivery in Tumor, Journal of Heat Transfer, 131, 4, 2009. Crossref

  5. El-Kareh Ardith W., Secomb Timothy W., A Mathematical Model for Comparison of Bolus Injection, Continuous Infusion, and Liposomal Delivery of Doxorubicin to Tumor Cells, Neoplasia, 2, 4, 2000. Crossref

  6. El-Ghannam Ahmed, Ricci Krista, Malkawi Ahmed, Jahed Kiarash, Vedantham Kumar, Wyan Heather, Allen Lauren D., Dréau Didier, A ceramic-based anticancer drug delivery system to treat breast cancer, Journal of Materials Science: Materials in Medicine, 21, 9, 2010. Crossref

  7. Raghunand N, Gatenby R A, Gillies R J, Microenvironmental and cellular consequences of altered blood flow in tumours, The British Journal of Radiology, 76, suppl_1, 2003. Crossref

  8. Forbes Z.G., Yellen B.B., Barbee K.A., Friedman G., An approach to targeted drug delivery based on uniform magnetic fields, IEEE Transactions on Magnetics, 39, 5, 2003. Crossref

  9. McDougall S. R., Chaplain M. A.J., Stéphanou A., Anderson A. R.A., Modelling the Impact of Pericyte Migration and Coverage of Vessels on the Efficacy of Vascular Disrupting Agents, Mathematical Modelling of Natural Phenomena, 5, 1, 2010. Crossref

  10. Prokop Ales, Davidson Jeffrey M., Nanovehicular Intracellular Delivery Systems, Journal of Pharmaceutical Sciences, 97, 9, 2008. Crossref

  11. Stéphanou A., McDougall S.R., Anderson A.R.A., Chaplain M.A.J., Mathematical modelling of flow in 2D and 3D vascular networks: Applications to anti-angiogenic and chemotherapeutic drug strategies, Mathematical and Computer Modelling, 41, 10, 2005. Crossref

  12. Feng Si-Shen, Chien Shu, Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases, Chemical Engineering Science, 58, 18, 2003. Crossref

  13. Stewart David J, Tomiak Eva, Shamji Farid M, Maziak Donna E, MacLeod Peter, Phase II study of alternating chemotherapy regimens for advanced non-small cell lung cancer, Lung Cancer, 44, 2, 2004. Crossref

  14. Gasselhuber Astrid, Dreher Matthew R., Partanen Ari, Yarmolenko Pavel S., Woods David, Wood Bradford J., Haemmerich Dieter, Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: Computational modelling and preliminaryin vivovalidation, International Journal of Hyperthermia, 28, 4, 2012. Crossref

  15. Thompson Matthew D., Beard Daniel A., Development of appropriate equations for physiologically based pharmacokinetic modeling of permeability-limited and flow-limited transport, Journal of Pharmacokinetics and Pharmacodynamics, 38, 4, 2011. Crossref

  16. McDougall Steven R., Anderson Alexander R.A., Chaplain Mark A.J., Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: Clinical implications and therapeutic targeting strategies, Journal of Theoretical Biology, 241, 3, 2006. Crossref

  17. Cheung Richard Y., Kuba Robert, Rauth Andrew M., Wu Xiao Yu, A new approach to the in vivo and in vitro investigation of drug release from locoregionally delivered microspheres, Journal of Controlled Release, 100, 1, 2004. Crossref

  18. Nicholson Charles, Diffusion and related transport mechanisms in brain tissue, Reports on Progress in Physics, 64, 7, 2001. Crossref

  19. Gang Jingu, Park Seong-Bae, Hyung Woochan, Choi Eric H., Wen Jing, Kim Han-Soo, Shul Young-Gun, Haam Seungjoo, Song Si Young, Magnetic poly ε-caprolactone nanoparticles containing Fe3O4and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model, Journal of Drug Targeting, 15, 6, 2007. Crossref

  20. Stapleton Shawn, Milosevic Michael, Allen Christine, Zheng Jinzi, Dunne Michael, Yeung Ivan, Jaffray David A., Chuu Chih-Pin, A Mathematical Model of the Enhanced Permeability and Retention Effect for Liposome Transport in Solid Tumors, PLoS ONE, 8, 12, 2013. Crossref

  21. Salloum M., Ma R., Zhu L., Enhancement in treatment planning for magnetic nanoparticle hyperthermia: Optimization of the heat absorption pattern, International Journal of Hyperthermia, 25, 4, 2009. Crossref

  22. Dewhirst Mark W., Secomb Timothy W., Transport of drugs from blood vessels to tumour tissue, Nature Reviews Cancer, 17, 12, 2017. Crossref

  23. Ganz Dan E., Sexton-Stallone Briana, Brackett Emily L., Forbes Neil S., Tissue transport affects how treatment scheduling increases the efficacy of chemotherapeutic drugs, Journal of Theoretical Biology, 438, 2018. Crossref

  24. Dermol-Černe Janja, Vidmar Janja, Ščančar Janez, Uršič Katja, Serša Gregor, Miklavčič Damijan, Connecting the in vitro and in vivo experiments in electrochemotherapy - a feasibility study modeling cisplatin transport in mouse melanoma using the dual-porosity model, Journal of Controlled Release, 286, 2018. Crossref

  25. Stapleton Shawn, Milosevic Michael F., Pressure Gradients in Solid Tumors, in Cancer Targeted Drug Delivery, 2013. Crossref

  26. Qin Shengping, Seo Jai Woong, Zhang Hua, Qi Jinyi, Curry Fitz-Roy E., Ferrara Katherine W., An Imaging-Driven Model for Liposomal Stability and Circulation, Molecular Pharmaceutics, 7, 1, 2010. Crossref

  27. McDougall Steven R., Dynamically Adaptive Tumour Induced Angiogenesis The Impact of Flow on the Developing Capillary Plexus, in Selected Topics in Cancer Modeling, 2008. Crossref

  28. Dunne Michael, Regenold Maximilian, Allen Christine, Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy, Advanced Drug Delivery Reviews, 163-164, 2020. Crossref

  29. Moradi Kashkooli Farshad, Soltani M., Evaluation of solid tumor response to sequential treatment cycles via a new computational hybrid approach, Scientific Reports, 11, 1, 2021. Crossref

  30. Curtis Chad, Zhang Mengying, Liao Rick, Wood Thomas, Nance Elizabeth, Systems‐level thinking for nanoparticle‐mediated therapeutic delivery to neurological diseases, WIREs Nanomedicine and Nanobiotechnology, 9, 2, 2017. Crossref

  31. Wolak Daniel J., Thorne Robert G., Diffusion of Macromolecules in the Brain: Implications for Drug Delivery, Molecular Pharmaceutics, 10, 5, 2013. Crossref

  32. Kalra Ashish V., Kim Jaeyeon, Klinz Stephan G., Paz Nancy, Cain Jason, Drummond Daryl C., Nielsen Ulrik B., Fitzgerald Jonathan B., Preclinical Activity of Nanoliposomal Irinotecan Is Governed by Tumor Deposition and Intratumor Prodrug Conversion, Cancer Research, 74, 23, 2014. Crossref

  33. Tzafriri Abraham Rami, Lerner Elyakum Itzhak, Flashner-Barak Moshe, Hinchcliffe Michael, Ratner Eli, Parnas Hanna, Mathematical Modeling and Optimization of Drug Delivery from Intratumorally Injected Microspheres, Clinical Cancer Research, 11, 2, 2005. Crossref

  34. Thurber Greg M., Reiner Thomas, Yang Katherine S., Kohler Rainer H., Weissleder Ralph, Effect of Small-Molecule Modification on Single-Cell Pharmacokinetics of PARP Inhibitors, Molecular Cancer Therapeutics, 13, 4, 2014. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain